Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
C
Celon Pharma SA
F:8RP
Celon Pharma SA
F:8RP
Price:
4.23
EUR
-0.47%
Market Closed
Market Cap:
€216m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Celon Pharma SA
F:8RP
|
PL |
|
Hammond Power Solutions Inc
F:T11
|
CA |
|
J
|
Japan Logistics Fund Inc
F:8UT
|
JP |
|
G
|
Glanbia PLC
SWB:GL9
|
IE |
Wall St Price Targets
8RP Price Forecast
Based on 8 analysts
Based on 8 analysts
+22% Upside
from
€4.23
today
Celon Pharma SA (8RP)’s 12-month stock price forecast through October 2027 has a consensus target of €5.17, implying 22% upside. The forecast is based on price targets from 8 Wall Street analysts.
Celon Pharma SA Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 8RP's stock price target?
Price Target
5.17
EUR
5.17
EUR
According to Wall Street analysts, the average 1-year price target for 8RP is 5.17 EUR with a low forecast of 4.13 EUR and a high forecast of 6.76 EUR.
What is the Revenue forecast for Celon Pharma SA?
Projected CAGR
13%
13%
Over the last 9 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 8 years is 13%.
What is the Gross Profit forecast for Celon Pharma SA?
Projected CAGR
19%
19%
Over the last 9 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next -4 years is 19%.